0.1430
-0.0205
(-12.54%)
At close: January 31 at 5:35:28 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating cash flow
-10,147.0000
-10,147.0000
-13,061.4000
-6,770.9000
-7,173.5000
Investing cash flow
50.8000
50.8000
-49.9000
-43.6000
-22.8000
Financing cash flow
6,323.2000
6,323.2000
13,098.7000
5,377.0000
8,148.7000
End cash position
1,827.4000
1,827.4000
5,593.3000
5,479.5000
6,842.9000
Capital expenditure
-25.0000
-25.0000
-57.4000
-43.6000
-23.3000
Issuance of capital stock
--
--
7,659.8000
6,022.0000
10,000.0000
Issuance of debt
6,925.0000
6,925.0000
6,463.1000
--
--
Repayment of debt
-328.2000
-328.2000
-160.4000
--
--
Repurchase of capital stock
--
--
--
--
-80.0000
Free cash flow
-10,172.0000
-10,172.0000
-13,118.8000
-6,814.5000
-7,196.8000
12/31/2020 - 4/15/2016
Upgrade to start utilising 40 years of financial statements and gain so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets and cash flows - all exportable.
UpgradeRelated tickers
0K4.BE Akero Therapeutics Inc
51.58
-4.02%
BPTSY Biophytis S.A.
2.7700
0.00%
ALSEN.PA Sensorion SA
0.6280
+1.62%
ALTME.PA TME Pharma N.V.
0.0702
+0.29%
ALBPS.PA Biophytis S.A.
0.2998
+1.39%
37Z.DU Allakos Inc
0.2333
+0.30%
48Q.F X4 Pharmaceuticals, Inc.
0.6300
-26.91%
TNG.PA Transgene SA
0.6930
-4.55%
BIOS.BR BioSenic S.A.
0.0036
0.00%
ADOC.PA Adocia SA
5.86
-0.34%